The following is a summary of “Unmasking High-Output Heart Failure: Beyond Conventional Paradigms,” published in the January ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for improved heart health.

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

Alleviant Medical, Inc., a privately held medical device company developing a no-implant atrial shunt for heart failure, ...

People with hidden pockets of fat in their muscles – similar to so-called marbling in beef – are at a higher risk of dying from heart attacks or heart failure regardless of their body weight, ...

GAITHERSBURG, MD, USA I2, 2025 I Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today ...

Preliminary findings from an 18-month study on acute coronary syndromes, conducted across several hospitals in Kuwait and ...

Stanford University School of Medicine–led researchers have found that intensive blood pressure (BP) control produces ...

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.

“We are committed to developing an effective treatment for patients suffering from heart failure with our minimally invasive, no-implant approach,” said Adam Berman, CEO of Alleviant Medical.